Skip to content
Tylenol Autism & ADHD Lawsuit Attorneys

Tylenol Autism & ADHD Lawsuit Attorneys

Acetaminophen, the main ingredient in Tylenol and other over-the-counter medications, may be linked to birth defects when taken during pregnancy. People whose children may have been harmed by pregnancy-related acetaminophen use may be eligible for compensation.

Open, accepting new clients
Free Consultation - No Obligation

Complete this form to have our firm review your case for free.


By submitting this form I agree to the terms of Disclaimer and Privacy Policy.

This field is for validation purposes and should be left unchanged.

Case Updates

  • 2/22/23

    Judge Cote issued an Order finalizing the protocol, rules and schedule for depositions and fact discovery of expert witnesses. Those depositions can now begin and will play a key role in an October 2023 hearing, when Judge Conte plans to rule the plaintiffs’ causation evidence.

  • 2/16/23

    As of February 16, 2022, 107 lawsuits have been filed in In Re: Acetaminophen – ASD/ADHD Products Liability Litigation.

  • 1/9/22

    The court approved a Short Form Complaint for new incoming plaintiffs to use when filing acetaminophen autism and ADHD lawsuits.

  • 11/15/22

    Judge Denise Cote denied Walmart’s motion to dismiss and explained that federal preemption does not apply. Judge Cote stated that the FDA regulation does not prohibit Walmart from changing the warning labels on its generic Tylenol products. She noted that the applicable federal labeling laws are not “exclusive” and do not limit a manufacturer’s obligation to ensure that its label is adequate.

  • 11/13/22

    Walmart filed a motion to dismiss the Tylenol autism cases based on federal preemption. The company argued that the FDA mandated the warning labels on these products under federal law; therefore, Walmart was not permitted to change the labels.

  • 10/5/22

    The Judicial Panel on Multidistrict Litigation consolidated 18 lawsuits alleging prenatal exposure to acetaminophen caused children to developed autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), or both for pretrial proceedings before U.S. District Judge Denise Cote in the Southern District of New York. The panel sent an additional 48 cases to the newly created multidistrict litigation the following day, saying the same scientific and legal questions underlie all of the cases.